Effects of hormone replacement therapy on mammographic findings

Archives of Gynecology and Obstetrics

Volumn 268, Issue 1, 2003, Pages 5-8

  Bülbül, Nur Hilal ^a   Özden, Selcuk ^a,b   Dayicioglu, Vedat ^a  

^a Z K Women/Child Educ/Res Hosp   (Turkey)

^b Ethem Efendi Cad   (Turkey)

Author keywords

Breast density; Hormone replacement therapy (HRT); Mammography; Tibolone

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; GESTAGEN; SEQUENTIAL CONTRACEPTIVE AGENT; TIBOLONE;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST EXAMINATION; BREAST TENDERNESS; CANCER RISK; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENOPAUSE; OBESITY; PROSPECTIVE STUDY;

EID: 0038173308     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-002-0306-7     Document Type: Article

References (27)

1. Steinberg KK, Thacker SB, Smith SJ, et al (1991) A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 265:1985-1990
2. Colditz GA, Egan KM, Stampfer MJ (1993) Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am J Obstet Gynecol 168:1473-1480
3. Colditz GA, Hankinson SE, Hunter DJ, et al (1995) The use of estrogens and progestins and the risk of breast cancer in post-menopausal women. N Engl J Med 332:1589-1593
4. Standford JL, Weiss NS, Voigt LF, et al (1995) Combined estrogens and progestin hormone replacement therapy in relationship to risk of breast cancer in middle aged women. JAMA 274:137-142
5. Speroff L, Glass RH, Kase MG (eds) (1999) Breast. In: Clinical gynecologic endocrinology and infertility, 6th edn. Lippincott Williams and Wilkins, Oregon, pp 595-643
6. Lundström E, Wilczek B, Von Palffy Z, et al (1999) Mammographic breast density during hormone replacement therapy; differences according to treatment. Am J Obstet Gynecol 181:348-352
7. Erel CT, Seyisolu H, entürk ML, et al (1996) Mammographic changes in women on hormonal replacement therapy. Maturitas 25:51-57
8. Özdemir A, Konuo O, Nas T, et al (1999) Mammographic and ultrasonographic study of changes in the breast related to HRT. Int J Gynaecol Obstet 67:23-32
9. Valdivia I, Ortega D (2000) Mammographic density in postmenopausal women treated with tibolone, estriol and conventional hormone replacement therapy, Clin Drug Invest 20:101-107
10. Palmer JR, Rosenberg L, Clarke EA, et al (1991) Breast cancer risk after estrogen replacement therapy: results from the Toronto Breast Cancer Study. Am J Epidemiol 134:1386-1395
11. Bergkvist L, Adami HO, Persson I, et al (1989) The risk of breast cancer after estrogen and estrogen progesterone replacement. N Engl J Med 321:293-297
12. Kaufman DW, Palmer JR, Mouzon J, et al (1991) Estrogen replacement therapy and the risk of breast cancer: Results from the cancer control surveillance study. Am J Epidemiol 134:1375-1385
13. WHO collaborative study of neoplasm and steroid contraception (1991) Breast cancer and depot-medroxy progesterone acetate. Lancet 338:833-838
14. Sillero-Arenas, Delgado-Rodriguez M, Rodigues-Canteras R, et al (1992) Menopausal hormone replacement therapy and breast cancer; A meta-analysis. Obstet Gynecol 79:286-295
15. Grady D. Rubin SM, Petitti DB, et al (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117:1016-1037
16. Dupont WD, Page DL, Rogers LW, Parl FF (1989) Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk. Cancer 63:948-457
17. Kaufman Z, Garstin WI, Hayes R, et al (1991) The mammographic parenchymal patterns of women on hormonal replacement therapy. Clin Radiol 43:389-392
18. McPherson K, Stell CM, Dixon JM (2000) ABC of breast diseases - Breast Cancer - epidemiology, risk factors and genetics. BMJ 321:624-628
19. Gambrell RD, Maier RC, Sanders BI (1983) Decreased incidence of breast cancer in postmenopausal estrogen-progesterone users. Obstet Gynecol 62:435-443
20. Meirik O, Lund E, Adami HO, et al (1986) Oral contraceptive use and breast cancer in young women. Lancet 94:650-654
21. McPherson K, Vessey MP, Neil A, et al (1987) Early oral contraceptive use and breast cancer: Results of another case-cohort study. Br J Cancer 56:653-660
22. Stomper PC, Van Voorhis BJ, Ravnikar VA, Meyer JE (1990) Mammographic hormone replacement therapy: A longitudinal study. Radiology 174:487-490
23. McNicholas MM, Heneghan JP, Milner MH, et al (1994) Pain and increased mammographic density in women receiving HRT: A prospective study. Am J Roentgenol 163:311-315
24. Hunt K, Vessey M, McPherson K, Coleman M (1987) Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol 94:620-635
25. Colacurci N, Mele D, De Franciscis P. et al (1998) Effects of tibolone on the breast. Eur J Obstet Gynecol Reprod Biol 80:235-238
26. Erel CT, Elter K, Akman Cersavasti G, et al (1998) Mammographic changes in women receiving tibolone therapy. Fertil Steril 69:870-875
27. Del Favero C, Rossini G, Tufarulo L, et al (1997) Mammography changes associated with hormone replacement therapy in post-menopausal patients. Radiol Med 93:210-213